Ask AI
ProCE Banner Activity

Current Treatment Options at First Relapse in Relapsed/Refractory Myeloma

Slideset Download
Download these expert-selected slides on current best practices for early stage relapsed/refractory multiple myeloma to help diagnose and manage your patients.

Released: June 07, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Director, Myeloma Clinical and Cellular Therapy Program
Professor of Medicine
Division of Hematology/Oncology/Stem Cell Therapy and Palliative Care
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin